Stock 2137 BRII BIOSCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Brii Biosciences Limited

Equities

2137

KYG1645A1094

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:28 2024-05-24 am EDT 		5-day change 1st Jan Change
1.27 HKD -2.31% Intraday chart for Brii Biosciences Limited -5.22% -44.30%
May. 15 Brii Bio's Hepatitis B Drugs Get Breakthrough Therapy Designation in China MT
Mar. 25 Transcript : Brii Biosciences Limited, 2023 Earnings Call, Mar 25, 2024

Business Summary

Brii Biosciences Ltd is a biotechnology company based in China and the United States principally engaged in developing therapies for infectious diseases. The Company’s products are applied in infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases, which have significant public health burdens. The Company is also developing therapies for COVID-19 and other diseases.

Number of employees: 128

Sales per Business

HKD in Million2022Weight2023Weight Delta
Therapies for Infectious Diseases and Central Nervous System Diseases
100.0 %
60 100.0 % 1 100.0 % -98.86%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
60 100.0 % 1 100.0 % -98.86%

Managers

Managers TitleAgeSince
Zhi Hong CEO
 Chief Executive Officer 60 17-12-07
An Kang Li DFI
 Director of Finance/CFO 47 20-08-31
David Margolis CTO
 Chief Tech/Sci/R&D Officer - -
Yao Zhang CTO
 Chief Tech/Sci/R&D Officer - -
Qing Zhu CTO
 Chief Tech/Sci/R&D Officer 57 18-04-01
Eleanor de Groot CTO
 Chief Tech/Sci/R&D Officer 55 22-08-14
Chris Fang IRC
 Investor Relations Contact - -
Karen D. Neuendorff HRO
 Human Resources Officer 49 22-01-26
Lisa Trivison Beck PRN
 Corporate Officer/Principal 62 18-03-11
Jean-Luc Samuel Francois Girardet PRN
 Corporate Officer/Principal 57 18-03-18

Members of the board

Members of the board TitleAgeSince
Gregg Alton BRD
 Director/Board Member 58 21-06-21
Tai Yin Yang BRD
 Director/Board Member 70 22-08-31
Robert Nelsen BRD
 Director/Board Member 60 18-06-21
Martin Murphy BRD
 Director/Board Member 81 21-06-21
Yiu Wa Tsui BRD
 Director/Board Member 74 21-06-21
Zhi Hong CEO
 Chief Executive Officer 60 17-12-07
Hui Tang BRD
 Director/Board Member 64 21-06-21
An Kang Li DFI
 Director of Finance/CFO 47 20-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 729,809,759 587,569,024 ( 80.51 %) 0 80.51 %

Shareholders

NameEquities%Valuation
Boyu Capital Advisory Co. Ltd.
9.871 %
72,019,612 9.871 % 12 M $
Shanghai Yunfeng Investment Management Co. Ltd.
4.943 %
36,069,510 4.943 % 6 M $
Hongshan
4.772 %
34,818,757 4.772 % 6 M $
Invesco Advisers, Inc.
4.626 %
33,751,238 4.626 % 5 M $
Zhi Hong
4.441 %
32,400,000 4.441 % 5 M $
GF Fund Management Co., Ltd.
0.9566 %
6,980,000 0.9566 % 1 M $
Bosera Asset Management Co., Ltd.
0.7769 %
5,668,500 0.7769 % 905 940 $
UBS Asset Management (Hong Kong) Ltd.
0.6220 %
4,538,000 0.6220 % 725 263 $
An Kang Li
0.1261 %
920,082 0.1261 % 147 048 $
CPIC Fund Management Co. Ltd.
0.0988 %
721,000 0.0988 % 115 230 $

Company contact information

Brii Biosciences Ltd. (China)

Zhongguancun Dongsheng, Building 7 1 North Yongtaizhuang Road

100192, Haidian

+

http://www.briibio.com
address Brii Biosciences Limited(2137)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.177 CNY
Average target price
5.536 CNY
Spread / Average Target
+370.24%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
BRII BIOSCIENCES LIMITED Stock Brii Biosciences Limited
-44.30% 119M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+12.30% 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.15% 106B
BIONTECH SE Stock BioNTech SE
-8.14% 23.4B
ARGENX SE Stock argenx SE
-1.69% 21.78B
GENMAB A/S Stock Genmab A/S
-10.60% 18.09B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.25% 16.72B
BEIGENE, LTD. Stock BeiGene, Ltd.
-15.33% 15.97B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.80% 14.03B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+28.03% 11.67B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2137 Stock
  4. Company Brii Biosciences Limited